| 產(chǎn)品編號(hào) | bsm-63002R |
| 英文名稱(chēng) | Thioredoxin Recombinant Rabbit mAb |
| 中文名稱(chēng) | 硫氧還蛋白重組兔單抗 |
| 別 名 | TXN; ADF; ATL-derived factor; SASP; Thioredoxin; TRX1; Thioredoxin delta 3; TRX; TXN delta 3; TRDX. |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Recombinant |
| 克 隆 號(hào) | 19C19 |
| 交叉反應(yīng) | Human,Mouse,Rat |
| 產(chǎn)品應(yīng)用 | WB=1:500-2000,Flow-Cyt=1:20-50
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 12 kDa |
| 檢測(cè)分子量 | 12 |
| 性 狀 | Liquid |
| 免 疫 原 | A synthesized peptide derived from human Thioredoxin: 80-105 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% Proclin300 and 50% glycerol. |
| 保存條件 | Store at 4℃ for short term. Store at -20℃ for long term. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions. Plays a role in the reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to the response to intracellular nitric oxide. Nitrosylates the active site Cys of CASP3 in response to nitric oxide (NO), and thereby inhibits caspase-3 activity. SWISS: P10599 Gene ID: 7295 硫氧還蛋白(Thioredoxin，Trx)是一類(lèi)廣泛存在于生物體內(nèi)的多功能酸性蛋白，分子量約12kDa，是一種小分子含硒蛋白質(zhì),參與細(xì)胞的一系列生化反應(yīng)，包括酶活性的調(diào)節(jié)、轉(zhuǎn)錄因子的調(diào)控等，是重要的酶活力調(diào)節(jié)蛋白。 硫氧還蛋白的功能絕大多數(shù)是依賴(lài)于硫氧還蛋白還原靶蛋白中的二硫鍵。所有硫氧還蛋白均有一個(gè)保守的活性中心，Trp-Cys-Gly(Ala)-Pro-Cys，活性中心有兩個(gè)具有氧還活性的半胱氨酸殘基。 |
| 產(chǎn)品圖片 |
25 ug total protein per lane of various lysates (see on figure) probed with Thioredoxin monoclonal antibody, unconjugated (bsm-63002R) at 1:2000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.
|
